BioSig Technologies announced the appointment of Anthony Amato to the position of Chief Executive Officer, effective immediately. Additionally, Amato will serve on the company’s board of directors, which is currently being assembled. “Recall, that on April 4, 2024, the company announced the engagement of Consulting firm, Bridge Associates International Pharmaceutical Consulting, led by Mr. Amato. This corporate action was the natural progression as the company continues to realize meaningful progress towards its goals of both resorting and creating lasting shareholder value,” BioSig stated.
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BSGM:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue